Experimental rhinovirus infection in COPD: Implications for antiviral therapies

Antiviral Research

Volumn 102, Issue , 2014, Pages 95-105

  Gunawardana, Natasha ^a   Finney, Lydia ^a   Johnston, Sebastian L ^a   Mallia, Patrick ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease (COPD); Exacerbations; Respiratory viruses; Rhinovirus

Indexed keywords

ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; BACTERIAL INFECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMON COLD; DISEASE EXACERBATION; HEALTH CARE NEED; HEALTH ECONOMICS; HUMAN; INFECTION SENSITIVITY; MOLECULAR MECHANICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RHINOVIRUS INFECTION; ANIMAL; CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD); DISEASE MODEL; EXACERBATIONS; ISOLATION AND PURIFICATION; PICORNAVIRUS INFECTION; RESPIRATORY VIRUSES; RHINOVIRUS; TREATMENT OUTCOME; VIROLOGY; DISEASE PREDISPOSITION; MEDICAL DECISION MAKING; MEDICAL RESEARCH; NONHUMAN; RESPIRATORY VIRUS; VIRUS INFECTION;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD); EXACERBATIONS; RESPIRATORY VIRUSES; RHINOVIRUS;

ANIMALS; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; HUMANS; PICORNAVIRIDAE INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RHINOVIRUS; TREATMENT OUTCOME;

EID: 84892142574     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.12.006     Document Type: Review

References (119)

1. S.D. Aaron, K.L. Vandemheen, F. Maltais, S.K. Field, D.D. Sin, J. Bourbeau, D.D. Marciniuk, J.M. FitzGerald, P. Nair, and R. Mallick TNFalpha antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial Thorax 68 2013 142 148
2. P. Almagro, E. Calbo, A. Ochoa de Echaguen, B. Barreiro, S. Quintana, J.L. Heredia, and J. Garau Mortality after hospitalization for COPD Chest 121 2002 1441 1448 (Pubitemid 34499653)
3. A. Antczak, M. Ciebiada, T. Pietras, W.J. Piotrowski, Z. Kurmanowska, and P. Gorski Exhaled eicosanoids and biomarkers of oxidative stress in exacerbation of chronic obstructive pulmonary disease Arch. Med. Sci. 8 2012 277 285
4. A. Anzueto, I. Leimer, and S. Kesten Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes Int. J. Chron. Obstruct. Pulm. Dis. 4 2009 245 251
5. M. Bafadhel, S. McKenna, S. Terry, V. Mistry, C. Reid, P. Haldar, M. McCormick, K. Haldar, T. Kebadze, A. Duvoix, K. Lindblad, H. Patel, P. Rugman, P. Dodson, M. Jenkins, M. Saunders, P. Newbold, R.H. Green, P. Venge, D.A. Lomas, M.R. Barer, S.L. Johnston, I.D. Pavord, and C.E. Brightling Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers Am. J. Respir. Crit. Care Med. 184 2011 662 671
6. M. Bafadhel, S. McKenna, S. Terry, V. Mistry, M. Pancholi, P. Venge, D.A. Lomas, M.R. Barer, S.L. Johnston, I.D. Pavord, and C.E. Brightling Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial Am. J. Respir. Crit. Care Med. 186 2012 48 55
7. K.J. Baines, A.C. Hsu, M. Tooze, L.P. Gunawardhana, P.G. Gibson, and P.A. Wark Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD Respir. Res. 14 2013 15
8. P.G. Bardin, D.J. Fraenkel, G. Sanderson, E.M. van Schalkwyk, S.T. Holgate, and S.L. Johnston Peak expiratory flow changes during experimental rhinovirus infection Eur. Respir. J. 16 2000 980 985 (Pubitemid 32049390)
9. P.J. Barnes Inhaled corticosteroids in COPD: a controversy Respiration 80 2010 89 95
10. N.W. Bartlett, R.P. Walton, M.R. Edwards, J. Aniscenko, G. Caramori, J. Zhu, N. Glanville, K.J. Choy, P. Jourdan, J. Burnet, T.J. Tuthill, M.S. Pedrick, M.J. Hurle, C. Plumpton, N.A. Sharp, J.N. Bussell, D.M. Swallow, J. Schwarze, B. Guy, J.W. Almond, P.K. Jeffery, C.M. Lloyd, A. Papi, R.A. Killington, D.J. Rowlands, E.D. Blair, N.J. Clarke, and S.L. Johnston Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation Nat. Med. 14 2008 199 204 (Pubitemid 351214556)
11. E. Bathoorn, J.J. Liesker, D.S. Postma, G.H. Koeter, M. van der Toorn, S. van der Heide, H.A. Ross, A.J. van Oosterhout, and H.A. Kerstjens Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation Int. J. Chron. Obstruct. Pulmon. Dis. 4 2009 101 109
12. J.D. Beckham, A. Cadena, J. Lin, P.A. Piedra, W.P. Glezen, S.B. Greenberg, and R.L. Atmar Respiratory viral infections in patients with chronic, obstructive pulmonary disease J. Infect. 50 2005 322 330 (Pubitemid 40533369)
13. A. Bhowmik, T.A. Seemungal, R.J. Sapsford, and J.A. Wedzicha Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations Thorax 55 2000 114 120 (Pubitemid 30245950)
14. W.A. Biernacki, S.A. Kharitonov, and P.J. Barnes Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD Thorax 58 2003 294 298 (Pubitemid 36411413)
15. Y.A. Bochkov, and J.E. Gern Clinical and molecular features of human rhinovirus C Microbes Infect. 14 2012 485 494
16. Boxall, C., Dudley, S., Beegan, R., Tear, V., Hrebien, S., Lunn, K., Monk, P., 2013. Effect of inhaled SNG001 (interferon-beta 1a) on sputum and blood antiviral biomarkers following a respiratory virus infection in asthmatic subjects. ERS Congress 2013. Abstract 4369.
17. S. Bozinovski, A. Hutchinson, M. Thompson, L. Macgregor, J. Black, E. Giannakis, A.S. Karlsson, R. Silvestrini, D. Smallwood, R. Vlahos, L.B. Irving, and G.P. Anderson Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 177 2008 269 278 (Pubitemid 351198369)
18. A.S. Buist, M.A. McBurnie, W.M. Vollmer, S. Gillespie, P. Burney, D.M. Mannino, A.M. Menezes, S.D. Sullivan, T.A. Lee, K.B. Weiss, R.L. Jensen, G.B. Marks, A. Gulsvik, E. Nizankowska-Mogilnicka, and Group B.C.R. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study Lancet 370 2007 741 750 (Pubitemid 47321907)
19. R.O. Buscho, D. Saxtan, P.S. Shultz, E. Finch, and M.A. Mufson Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis J. Infect. Dis. 137 1978 377 383 (Pubitemid 8327250)
20. P.M. Calverley, J.A. Anderson, B. Celli, G.T. Ferguson, C. Jenkins, P.W. Jones, J.C. Yates, J. Vestbo, and Investigators T Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N. Engl. J. Med. 356 2007 775 789 (Pubitemid 46294610)
21. C.A. Camargo Jr., A.A. Ginde, S. Clark, C.P. Cartwright, A.R. Falsey, and D.E. Niewoehner Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease Intern. Emerg. Med. 3 2008 355 359
22. R.J. Cameron, D. de Wit, T.N. Welsh, J. Ferguson, T.V. Grissell, and P.J. Rye Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation Intensive Care Med. 32 2006 1022 1029 (Pubitemid 43952717)
23. C. Cates Inhaled corticosteroids in COPD: quantifying risks and benefits Thorax 68 2013 499 500
24. B.R. Celli, N.E. Thomas, J.A. Anderson, G.T. Ferguson, C.R. Jenkins, P.W. Jones, J. Vestbo, K. Knobil, J.C. Yates, and P.M. Calverley Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study Am. J. Respir. Crit. Care Med. 178 2008 332 338
25. T. Chiba, J. Chihara, and M. Furue Role of the Arylhydrocarbon Receptor (AhR) in the pathology of asthma and COPD J. Allergy 2012 2012 372384
26. A.F. Connors Jr., N.V. Dawson, C. Thomas, F.E. Harrell Jr., N. Desbiens, W.J. Fulkerson, P. Kussin, P. Bellamy, L. Goldman, and W.A. Knaus Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) Am. J. Respir. Crit. Care Med. 154 1996 959 967
27. M. Contoli, S.D. Message, V. Laza-Stanca, M.R. Edwards, P.A. Wark, N.W. Bartlett, T. Kebadze, P. Mallia, L.A. Stanciu, H.L. Parker, L. Slater, A. Lewis-Antes, O.M. Kon, S.T. Holgate, D.E. Davies, S.V. Kotenko, A. Papi, and S.L. Johnston Role of deficient type III interferon-lambda production in asthma exacerbations Nat. Med. 12 2006 1023 1026 (Pubitemid 44353382)
28. G. De Serres, N. Lampron, J. La Forge, I. Rouleau, J. Bourbeau, K. Weiss, B. Barret, and G. Boivin Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations J. Clin. Virol. 46 2009 129 133
29. M. Decramer, W. Janssens, and M. Miravitlles Chronic obstructive pulmonary disease Lancet 379 2012 1341 1351
30. P.N. Dekhuijzen, K.K. Aben, I. Dekker, L.P. Aarts, P.L. Wielders, C.L. van Herwaarden, and A. Bast Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 154 1996 813 816 (Pubitemid 26327310)
31. A. Di Stefano, G. Turato, P. Maestrelli, C.E. Mapp, M.P. Ruggieri, A. Roggeri, P. Boschetto, L.M. Fabbri, and M. Saetta Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa Am. J. Respir. Crit. Care Med. 153 1996 629 632 (Pubitemid 26051339)
32. A. Di Stefano, A. Capelli, M. Lusuardi, P. Balbo, C. Vecchio, P. Maestrelli, C.E. Mapp, L.M. Fabbri, C.F. Donner, and M. Saetta Severity of airflow limitation is associated with severity of airway inflammation in smokers Am. J. Respir. Crit. Care Med. 158 1998 1277 1285 (Pubitemid 28489033)
33. G. Dimopoulos, M. Lerikou, S. Tsiodras, A. Chranioti, E. Perros, U. Anagnostopoulou, A. Armaganidis, and P. Karakitsos Viral epidemiology of acute exacerbations of chronic obstructive pulmonary disease Pulm. Pharmacol. Ther. 25 2012 12 18
34. G.C. Donaldson, T.A. Seemungal, A. Bhowmik, and J.A. Wedzicha Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease Thorax 57 2002 847 852 (Pubitemid 35178607)
35. G.C. Donaldson, T.M. Wilkinson, J.R. Hurst, W.R. Perera, and J.A. Wedzicha Exacerbations and time spent outdoors in chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 171 2005 446 452 (Pubitemid 40444244)
36. E.M. Drost, K.M. Skwarski, J. Sauleda, N. Soler, J. Roca, A. Agusti, and W. MacNee Oxidative stress and airway inflammation in severe exacerbations of COPD Thorax 60 2005 293 300 (Pubitemid 40522365)
37. A.R. Falsey, M.A. Formica, P.A. Hennessey, M.M. Criddle, W.M. Sullender, and E.E. Walsh Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 173 2006 639 643 (Pubitemid 43363805)
38. T.L. Feenstra, M.L. van Genugten, R.T. Hoogenveen, E.F. Wouters, and M.P. Rutten-van Molken The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands Am. J. Respir. Crit. Care Med. 164 2001 590 596 (Pubitemid 32801662)
39. L.J. Finney, J.R. Feary, J. Leonardi-Bee, S.B. Gordon, and K. Mortimer Chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review Int. J. Tuberc. Lung Dis. 17 2013 583 589
40. K. Fujimoto, M. Yasuo, K. Urushibata, M. Hanaoka, T. Koizumi, and K. Kubo Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Eur. Respir. J. 25 2005 640 646 (Pubitemid 40528756)
41. E. Gamble, D.C. Grootendorst, K. Hattotuwa, T. O'Shaughnessy, F.S. Ram, Y. Qiu, J. Zhu, A.M. Vignola, C. Kroegel, F. Morell, I.D. Pavord, K.F. Rabe, P.K. Jeffery, and N.C. Barnes Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis Eur. Respir. J. 30 2007 467 471 (Pubitemid 351182069)
42. George, S., Garcha, D.S., Patel, A., Mackay, A.J., Singh, R., Donaldson, G.C., Sapsford, R.J., Wedzicha, A.J., 2013. Human rhinovirus infection and secondary bacterial infection in copd exacerbations. 10.1164/ajrccm-conference. 2013.187.1-MeetingAbstracts.A2164.
43. J.E. Gern, R. Vrtis, K.A. Grindle, C. Swenson, and W.W. Busse Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection Am. J. Respir. Crit. Care Med. 162 2000 2226 2231 (Pubitemid 32051692)
44. N. Glanville, G.R. McLean, B. Guy, V. Lecouturier, C. Berry, Y. Girerd, C. Gregoire, R.P. Walton, R.M. Pearson, T. Kebadze, N. Burdin, N.W. Bartlett, J.W. Almond, and S.L. Johnston Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein PLoS Pathog. 9 2013 e1003669
45. K.H. Groenewegen, A.M. Schols, and E.F. Wouters Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD Chest 124 2003 459 467 (Pubitemid 37000120)
46. K. Grunberg, R.F. Sharon, J.K. Sont, J.C. In 't Veen, W.A. Van Schadewijk, E.P. De Klerk, C.R. Dick, J.H. Van Krieken, and P.J. Sterk Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection Am. J. Respir. Crit. Care Med. 164 2001 1816 1822 (Pubitemid 33152313)
47. F.G. Hayden, and J.M. Gwaltney Jr. Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection Antimicrob. Agents Chemother. 21 1982 892 897 (Pubitemid 12012603)
48. F.G. Hayden, and J.M. Gwaltney Jr. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds J. Infect. Dis. 150 1984 174 180 (Pubitemid 14073356)
49. F.G. Hayden, J.M. Gwaltney Jr., and R.J. Colonno Modification of experimental rhinovirus colds by receptor blockade Antivir. Res. 9 1988 233 247
50. F.G. Hayden, K. Andries, and P.A. Janssen Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection Antimicrob. Agents Chemother. 36 1992 727 732
51. F.G. Hayden, G.J. Hipskind, D.H. Woerner, G.F. Eisen, M. Janssens, P.A. Janssen, and K. Andries Intranasal pirodavir (R77,975) treatment of rhinovirus colds Antimicrob. Agents Chemother. 39 1995 290 294
52. F.G. Hayden, D.T. Herrington, T.L. Coats, K. Kim, E.C. Cooper, S.A. Villano, S. Liu, S. Hudson, D.C. Pevear, M. Collett, and M. McKinlay Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials Clin. Infect. Dis. 36 2003 1523 1532 (Pubitemid 36783334)
53. F.G. Hayden, R.B. Turner, J.M. Gwaltney, K. Chi-Burris, M. Gersten, P. Hsyu, A.K. Patick, G.J. Smith 3rd, and L.S. Zalman Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers Antimicrob.Agents Chemother. 47 2003 3907 3916 (Pubitemid 37485007)
54. J.C. Hogg, and W. Timens The pathology of chronic obstructive pulmonary disease Ann. Rev. Pathol. 4 2009 435 459
55. J.R. Hurst, G.C. Donaldson, T.M.A. Wilkinson, W.R. Perera, and J.A. Wedzicha Epidemiological relationships between the common cold and exacerbation frequency in COPD Eur. Respir. J. 26 2005 846 852 (Pubitemid 41632041)
56. J.R. Hurst, W.R. Perera, T.M. Wilkinson, G.C. Donaldson, and J.A. Wedzicha Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 173 2006 71 78 (Pubitemid 43069790)
57. J.R. Hurst, J. Vestbo, A. Anzueto, N. Locantore, H. Mullerova, R. Tal-Singer, B. Miller, D.A. Lomas, A. Agusti, W. Macnee, P. Calverley, S. Rennard, E.F. Wouters, J.A. Wedzicha, and Evaluation of C.L.t.I.P.S.E.I. Susceptibility to exacerbation in chronic obstructive pulmonary disease N. Engl. J. Med. 363 2010 1128 1138
58. A.F. Hutchinson, A.K. Ghimire, M.A. Thompson, J.F. Black, C.A. Brand, A.J. Lowe, D.M. Smallwood, R. Vlahos, S. Bozinovski, G.V. Brown, G.P. Anderson, and L.B. Irving A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD Respir. Med. 101 2007 2472 2481 (Pubitemid 47618387)
59. S.E. Jacobs, D.M. Lamson, K. St George, and T.J. Walsh Human rhinoviruses Clin. Microbiol. Rev. 26 2013 135 162
60. S.L. Johnston, P.K. Pattemore, G. Sanderson, S. Smith, M.J. Campbell, L.K. Josephs, A. Cunningham, B.S. Robinson, S.H. Myint, M.E. Ward, D.A. Tyrrell, and S.T. Holgate The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis Am. J. Respir. Crit. Care Med. 154 1996 654 660 (Pubitemid 26327287)
61. R.E. Kanner, N.R. Anthonisen, and J.E. Connett Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study Am. J. Respir. Crit. Care Med. 164 2001 358 364 (Pubitemid 32778199)
62. J.L. Kennedy, R.B. Turner, T. Braciale, P.W. Heymann, and L. Borish Pathogenesis of rhinovirus infection Curr. Opin. Virol. 2 2012 287 293
63. A.L. Kersul, A. Iglesias, A. Rios, A. Noguera, A. Forteza, E. Serra, A. Agusti, and B.G. Cosio Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease Arch. Bronconeumol. 47 2011 176 183
64. O. Kherad, L. Kaiser, P.O. Bridevaux, F. Sarasin, Y. Thomas, J.P. Janssens, and O.T. Rutschmann Upper-respiratory viral infection, biomarkers, and COPD exacerbations Chest 138 2010 896 904
65. F.W. Ko, M. Ip, P.K. Chan, M.C. Chan, K.W. To, S.S. Ng, S.S. Chau, J.W. Tang, and D.S. Hui Viral etiology of acute exacerbations of COPD in Hong Kong Chest 132 2007 900 908
66. A. Koutsokera, T.S. Kiropoulos, D.J. Nikoulis, Z.D. Daniil, V. Tsolaki, K. Tanou, A.I. Papaioannou, A. Germenis, K.I. Gourgoulianis, and K. Kostikas Clinical, functional and biochemical changes during recovery from COPD exacerbations Respir. Med. 103 2009 919 926
67. J.D. Leuppi, P. Schuetz, R. Bingisser, M. Bodmer, M. Briel, T. Drescher, U. Duerring, C. Henzen, Y. Leibbrandt, S. Maier, D. Miedinger, B. Muller, A. Scherr, C. Schindler, R. Stoeckli, S. Viatte, C. von Garnier, M. Tamm, and J. Rutishauser Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial JAMA 309 2013 2223 2231
68. R.A. Levandowski, C.T. Pachucki, M. Rubenis, and G.G. Jackson Topical enviroxime against rhinovirus infection Antimicrob. Agents Chemother. 22 1982 1004 1007 (Pubitemid 13190652)
69. A.J. Mackay, and J.R. Hurst COPD exacerbations: causes, prevention, and treatment Immunol. Allergy Clin. North Am. 33 2013 95 115
70. P. Mallia, S.D. Message, T. Kebadze, H.L. Parker, O.M. Kon, and S.L. Johnston An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study Respir. Res. 7 2006 116
71. P. Mallia, S.D. Message, V. Gielen, M. Contoli, K. Gray, T. Kebadze, J. Aniscenko, V. Laza-Stanca, M.R. Edwards, L. Slater, A. Papi, L.A. Stanciu, O.M. Kon, M. Johnson, and S.L. Johnston Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation Am. J. Respir. Crit. Care Med. 183 2011 734 742
72. P. Mallia, J. Footitt, R. Sotero, A. Jepson, M. Contoli, M.B. Trujillo-Torralbo, T. Kebadze, J. Aniscenko, G. Oleszkiewicz, K. Gray, S.D. Message, K. Ito, P.J. Barnes, I.M. Adcock, A. Papi, L.A. Stanciu, S.L. Elkin, O.M. Kon, M. Johnson, and S.L. Johnston Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 186 2012 1117 1124
73. P. Mallia, S.D. Message, M. Contoli, K. Gray, A. Telcian, V. Laza-Stanca, A. Papi, L.A. Stanciu, S. Elkin, O.M. Kon, M. Johnson, and S.L. Johnston Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease Respir. Med. 2013 [Epub ahead of print]
74. P. Mallia, S.D. Message, M. Contoli, K.K. Gray, A. Telcian, V. Laza-Stanca, A. Papi, L.A. Stanciu, S. Elkin, O.M. Kon, M. Johnson, and S.L. Johnston Neutrophil adhesion molecules in experimental rhinovirus infection in COPD Respir. Res. 14 2013 72
75. C.D. Mathers, and D. Loncar Projections of global mortality and burden of disease from 2002 to 2030 PLoS Med. 3 2006 e442
76. T.E. McManus, A.M. Marley, N. Baxter, S.N. Christie, H.J. O'Neill, J.S. Elborn, P.V. Coyle, and J.C. Kidney Respiratory viral infection in exacerbations of COPD Respir. Med. 102 2008 1575 1580
77. A.M. Menezes, R. Perez-Padilla, J.R. Jardim, A. Muino, M.V. Lopez, G. Valdivia, M. Montes de Oca, C. Talamo, P.C. Hallal, and C.G. Victora Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study Lancet 366 2005 1875 1881 (Pubitemid 41690116)
78. P.F. Mercer, J.K. Shute, A. Bhowmik, G.C. Donaldson, J.A. Wedzicha, and J.A. Warner MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation Respir. Res. 6 2005 151
79. S.D. Message, V. Laza-Stanca, P. Mallia, H.L. Parker, J. Zhu, T. Kebadze, M. Contoli, G. Sanderson, O.M. Kon, A. Papi, P.K. Jeffery, L.A. Stanciu, and S.L. Johnston Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production Proc. Natl. Acad. Sci. USA 105 2008 13562 13567
80. P.L. Molyneaux, P. Mallia, M.J. Cox, J. Footitt, S.A. Willis-Owen, D. Homola, M.B. Trujillo-Torralbo, S. Elkin, O.M. Kon, W.O. Cookson, M.F. Moffatt, and S.L. Johnston Outgrowth of the bacterial airway microbiome following rhinovirus exacerbation of chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 188 2013 1224 1231
81. T.F. Murphy, and S. Sethi Bacterial infection in chronic obstructive pulmonary disease Am. Rev. Respir. Dis. 146 1992 1067 1083
82. E.J. Oudijk, W.B. Gerritsen, E.H. Nijhuis, D. Kanters, B.L. Maesen, J.W. Lammers, and L. Koenderman Expression of priming-associated cellular markers on neutrophils during an exacerbation of COPD Respir. Med. 100 2006 1791 1799 (Pubitemid 44307951)
83. S. Pant, E.H. Walters, A. Griffiths, R. Wood-Baker, D.P. Johns, and D.W. Reid Airway inflammation and anti-protease defences rapidly improve during treatment of an acute exacerbation of COPD Respirology (Carlton, Vic.) 14 2009 495 503
84. A. Papi, C.M. Bellettato, F. Braccioni, M. Romagnoli, P. Casolari, G. Caramori, L.M. Fabbri, and S.L. Johnston Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations Am. J. Respir. Crit. Care Med. 173 2006 1114 1121 (Pubitemid 43726892)
85. P.N. Perera, E.P. Armstrong, D.L. Sherrill, and G.H. Skrepnek Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality COPD 9 2012 131 141
86. J.M. Perotin, S. Dury, F. Renois, G. Deslee, A. Wolak, V. Duval, C. De Champs, F. Lebargy, and L. Andreoletti Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study J. Med. Virol. 85 2013 866 873
87. R.J. Phillpotts, J. Wallace, D.A. Tyrrell, and V.B. Tagart Therapeutic activity of enviroxime against rhinovirus infection in volunteers Antimicrob. Agents Chemother. 23 1983 671 675 (Pubitemid 13087001)
88. A.R. Pons, J. Sauleda, A. Noguera, J. Pons, B. Barcelo, A. Fuster, and A.G. Agusti Decreased macrophage release of TGF-beta and TIMP-1 in chronic obstructive pulmonary disease Eur. Respir. J. 26 2005 60 66 (Pubitemid 40945932)
89. J.K. Quint, G.C. Donaldson, J.J.P. Goldring, R. Baghai-Ravary, J.R. Hurst, and J.A. Wedzicha SErum ip-10 as a biomarker of human rhinovirus infection at exacerbation of copd CHEST J. 137 2010 812 822
90. G. Rohde, A. Wiethege, I. Borg, M. Kauth, T.T. Bauer, A. Gillissen, A. Bufe, and G. Schultze-Werninghaus Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study Thorax 58 2003 37 42 (Pubitemid 36135356)
91. G. Rohde, I. Borg, A. Wiethege, M. Kauth, S. Jerzinowski, T.An. Duong Dinh, T.T. Bauer, A. Bufe, and G. Schultze-Werninghaus Inflammatory response in acute viral exacerbations of COPD Infection 36 2008 427 433
92. M. Roland, A. Bhowmik, R.J. Sapsford, T.A. Seemungal, D.J. Jeffries, T.D. Warner, and J.A. Wedzicha Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease Thorax 56 2001 30 35 (Pubitemid 32041716)
93. U. Sajjan, S. Ganesan, A.T. Comstock, J. Shim, Q. Wang, D.R. Nagarkar, Y. Zhao, A.M. Goldsmith, J. Sonstein, M.J. Linn, J.L. Curtis, and M.B. Hershenson Elastase- and LPS-exposed mice display altered responses to rhinovirus infection Am. J. Physiol. Lung Cell. Mol. Physiol. 297 2009 L931 L944
94. S.K. Sandhu, J. Chu, M. Yurkovich, D. Harriman, C. Taraboanta, and J.M. Fitzgerald Variations in the management of acute exacerbations of chronic obstructive pulmonary disease Can. Respir. J. 20 2013 175 179
95. G.M. Schiff, and J.R. Sherwood Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection J. Infect. Dis. 181 2000 20 26 (Pubitemid 30049028)
96. D. Schneider, S. Ganesan, A.T. Comstock, C.A. Meldrum, R. Mahidhara, A.M. Goldsmith, J.L. Curtis, F.J. Martinez, M.B. Hershenson, and U. Sajjan Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 182 2010 332 340
97. T.A. Seemungal, G.C. Donaldson, E.A. Paul, J.C. Bestall, D.J. Jeffries, and J.A. Wedzicha Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 157 1998 1418 1422
98. T.A. Seemungal, G.C. Donaldson, A. Bhowmik, D.J. Jeffries, and J.A. Wedzicha Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 161 2000 1608 1613 (Pubitemid 30329036)
99. T.A. Seemungal, R. Harper-Owen, A. Bhowmik, D.J. Jeffries, and J.A. Wedzicha Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease Eur. Respir. J. 16 2000 677 683
100. T. Seemungal, R. Harper-Owen, A. Bhowmik, I. Moric, G. Sanderson, S. Message, P. Maccallum, T.W. Meade, D.J. Jeffries, S.L. Johnston, and J.A. Wedzicha Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 164 2001 1618 1623 (Pubitemid 33124148)
101. K. Senior FDA panel rejects common cold treatment Lancet Infect. Dis. 2 2002 264
102. S. Sethi Molecular diagnosis of respiratory tract infection in acute exacerbations of chronic obstructive pulmonary disease Clin. Infect. Dis. 52 Suppl. 4 2011 S290 S295
103. A. Singanayagam, J.D. Chalmers, and A.T. Hill Inhaled corticosteroids and risk of pneumonia: evidence for and against the proposed association QJM 103 2010 379 385
104. M. Singh, S.H. Lee, P. Porter, C. Xu, A. Ohno, R.L. Atmar, S.B. Greenberg, V. Bandi, J. Gern, S. Amineva, A. Aminev, T. Skern, P. Smithwick, S. Perusich, N. Barrow, L. Roberts, D.B. Corry, and F. Kheradmand Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease J. Allergy Clin. Immunol. 125 1369-1378 2010 e1362
105. C.B. Smith, C.A. Golden, R.E. Kanner, and A.D. Renzetti Jr. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases Am. Rev. Respir. Dis. 121 1980 225 232 (Pubitemid 10095215)
106. D. Stolz, M. Christ-Crain, R. Bingisser, J. Leuppi, D. Miedinger, C. Muller, P. Huber, B. Muller, and M. Tamm Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy Chest 131 2007 9 19 (Pubitemid 46122969)
107. S. Suissa, and P.J. Barnes Inhaled corticosteroids in COPD: the case against Eur. Respir. J. 34 2009 13 16
108. W.C. Tan, X. Xiang, D. Qiu, T.P. Ng, S.F. Lam, and R.G. Hegele Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease Am. J. Med. 115 2003 272 277 (Pubitemid 37088188)
109. S. Traub, A. Nikonova, A. Carruthers, R. Dunmore, K.A. Vousden, L. Gogsadze, W. Hao, Q. Zhu, K. Bernard, J. Zhu, M. Dymond, G.R. McLean, R.P. Walton, N. Glanville, A. Humbles, M. Khaitov, T. Wells, R. Kolbeck, A.J. Leishman, M.A. Sleeman, N.W. Bartlett, and S.L. Johnston An anti-human icam-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation PLoS Pathog. 9 2013 e1003520
110. M. Tsoumakidou, N. Tzanakis, G. Chrysofakis, and N.M. Siafakas Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD Chest 127 2005 1911 1918
111. R.B. Turner, F.J. Dutko, N.H. Goldstein, G. Lockwood, and F.G. Hayden Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection Antimicrob. Agents Chemother. 37 1993 297 300 (Pubitemid 23046572)
112. R.B. Turner, M.T. Wecker, G. Pohl, T.J. Witek, E. McNally, R. St George, B. Winther, and F.G. Hayden Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial JAMA 281 1999 1797 1804 (Pubitemid 29231129)
113. Van Beurden, W.J., Smeenk, F.W., Harff, G.A., Dekhuijzen, P.N., 2003. Markers of inflammation and oxidative stress during lower respiratory tract infections in COPD patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace/Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Universita di Napoli, Secondo ateneo 59, 273-280. (Pubitemid 38745284)
114. R.N. van Zyl Smit, M. Pai, W.W. Yew, C.C. Leung, A. Zumla, E.D. Bateman, and K. Dheda Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD Eur. Respir. J. 35 2010 27 33
115. J. Vestbo, S.S. Hurd, A.G. Agusti, P.W. Jones, C. Vogelmeier, A. Anzueto, P.J. Barnes, L.M. Fabbri, F.J. Martinez, M. Nishimura, R.A. Stockley, D.D. Sin, and R. Rodriguez-Roisin Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am. J. Respir. Crit. Care Med. 187 2013 347 365
116. D.J. Vollenweider, H. Jarrett, C.A. Steurer-Stey, J. Garcia-Aymerich, and M.A. Puhan Antibiotics for exacerbations of chronic obstructive pulmonary disease Cochrane Database Syst. Rev. 12 2012 CD010257
117. J.A. Walters, P.G. Gibson, R. Wood-Baker, M. Hannay, and E.H. Walters Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease Cochrane Database Syst. Rev. 1 2009 CD001288
118. J.A. Wedzicha Antibiotics at COPD exacerbations: the debate continues Thorax 63 2008 940 942
119. J.A. Wedzicha, P.M. Calverley, T.A. Seemungal, G. Hagan, Z. Ansari, R.A. Stockley, and I. Investigators The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide Am. J. Respir. Crit. Care Med. 177 2008 19 26